{
    "Trade/Device Name(s)": [
        "Abbott AxSYM\u00ae Troponin-I ADV Reagent",
        "Abbott AxSYM\u00ae Troponin-I ADV Assay"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K060875",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "March 29, 2006",
    "Summary Letter Received Date": "March 30, 2006",
    "Submission Date": "March 29, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiac"
    ],
    "Analyte(s)": [
        "Troponin-I (cTnI)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AxSYM System"
    ],
    "Method(s)/Technology(ies)": [
        "Microparticle Enzyme Immunoassay (MEIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott AxSYM Troponin-I ADV reagent for quantitative measurement of cardiac troponin-I by MEIA on AxSYM System",
    "Indications for Use Summary": "Quantitative determination of cardiac troponin-I in serum or plasma to assist in diagnosis of myocardial infarction and risk stratification of patients with acute coronary syndromes",
    "fda_folder": "Clinical Chemistry"
}